UBS Group’s Global X Cannabis ETF POTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-33
Closed -$193 10459
2023
Q4
$193 Buy
+33
New +$188 ﹤0.01% 8824
2023
Q3
Sell
-339
Closed -$2.16K 10383
2023
Q2
$2.16K Sell
339
-18,179
-98% -$144K ﹤0.01% 7802
2023
Q1
$168K Buy
18,518
+15,843
+592% +$174K ﹤0.01% 5524
2022
Q4
$29.8K Buy
2,675
+2,625
+5,250% +$37.2K ﹤0.01% 7248
2022
Q3
$1K Sell
50
-40
-44% -$673 ﹤0.01% 10250
2022
Q2
$1K Buy
90
+59
+190% +$1.33K ﹤0.01% 10204
2022
Q1
$1K Buy
+31
New +$968 ﹤0.01% 10132
2021
Q4
Sell
-138
Closed -$7K 11208
2021
Q3
$7K Buy
138
+111
+411% +$7.2K ﹤0.01% 8381
2021
Q2
$2K Buy
+27
New +$2.32K ﹤0.01% 9072
2020
Q3
Sell
-279
Closed -$17K 8628
2020
Q2
$17K Buy
+279
New +$17.4K ﹤0.01% 6673

Other funds holding POTX

UBS Group's POTX Position: Q1 2024 in Review

UBS Group sold out of Global X Cannabis ETF (POTX) in Q1 2024, closing a stake of 33 shares — an estimated $193 sold.

UBS Group first reported a position in POTX in Q2 2020 and held it in 10 quarters. The position peaked at $168K in Q1 2023. 1 fund tracked by Wall St. Rank holds POTX as of Q1 2024.

  • UBS Group reported no remaining Global X Cannabis ETF position as of Q1 2024 after selling out during the quarter.
  • UBS Group sold 33 Global X Cannabis ETF shares in Q1 2024, an estimated $193.
  • UBS Group first reported a position in Global X Cannabis ETF in Q2 2020 and held it in 10 quarters.
  • UBS Group's Global X Cannabis ETF position peaked at $168K in Q1 2023.
  • 1 fund tracked by Wall St. Rank held Global X Cannabis ETF as of Q1 2024.

Based on UBS Group's 13F filing for Q1 2024, filed 13 May 2024.